Glycised tab. 100 mg .50

Medicinal form. Tablets.

The main physicochemical properties: tablets are almost white or white with a creamy shade of color, round in shape with a flat surface with a chamfer. The surface of the tablets may be marble.

Pharmacotherapeutic group. Means affecting the nervous system.

ATX code N07X X.

Pharmacological properties.

Glycine is a substitute amino acid (natural metabolite), is a neurotransmitter of the inhibitory type of action and a regulator of metabolic processes in the central nervous system, reduces psycho-emotional stress, increases mental performance, exhibits neuroprotective, anti-stress, sedative effects, improves brain metabolism, normalizes sleep, reduces toxic effects alcohol Does not cause addiction.

Easily penetrates most biological fluids and body tissues, including the brain. It is quickly destroyed in the liver by glycine oxidase, disintegrating into water and carbon dioxide. Accumulation of glycine in tissues does not occur.
Indication.

Functional and organic diseases of the nervous system (neuroses, neurosis-like states, vegetative-vascular dystonias, consequences of neuroinfection, brain injury, perinatal and other forms of encephalopathy, including alcoholic genesis), which are accompanied by increased excitability, emotional instability, reduced mental capacity, sleep disturbance.

Ischemic stroke and impaired cerebral circulation.

As an aid in the treatment of alcoholism.

Contraindication.

Individual intolerance of the medicinal product and increased sensitivity to its individual components; arterial hypotension. Children’s age up to 3 years.

Special security measures.

If the patient is prone to arterial hypotension, it is necessary to monitor blood pressure and, if necessary, correct the dose of the drug: Glicised® is prescribed in smaller doses and under the condition of regular control of blood pressure. If the blood pressure drops below the usual level, the drug is stopped.

Method of application and dosage.

Glycysed® medicine is used in tablets or in the form of powder after crushing the tablet transbuccally (by placement behind the cheek or in the oral cavity) or sublingually (under the tongue). The tablet is kept in the oral cavity until it is completely dissolved.

Children over 3 years of age, adolescents, and adults with reduced mental capacity are prescribed Glicised® 1 tablet (100 mg) 2─3 times a day for 14─30 days. The maximum daily dose is 300 mg.

Children aged 3 years and older and adults with increased excitability, emotional lability are prescribed 1 tablet 2─3 times a day, the course of treatment─7─14 days. If necessary, the course of treatment is repeated.

For sleep disorders, 50─100 mg are prescribed 20 minutes before bedtime or immediately before bedtime.

In case of ischemic cerebral stroke and disorders of cerebral blood circulation, 1 g of the drug is prescribed transbuccally or sublingually (if necessary, the tablet should be crushed) during the first 3─6 hours after the development of the stroke, then─for 1─5 days at 1 g per day, then for 6─30 days ─ 1─2 tablets 3 times a day.

In the treatment of alcoholism, the drug is prescribed as an auxiliary agent, 1 tablet 2─3 times a day for 14─30 days. If necessary, the course of treatment is repeated 4─6 times a year.
Expiry date.

3 years. Do not use after the expiration date indicated on the package.

Storage conditions.

Store in the original packaging, at a temperature not higher than 25 ° C.

Store in a place inaccessible to children.

Packaging.

10 tablets in a blister. 5 blisters in a pack.

Leave category.

Without a prescription.

Manufacturer.

PJSC “Kyivmedpreparat”.